Arek Dudek

Arek serves as the Company’s Clinical Advisory Board Chairman. He brings to Vanquish over 15 years of cancer clinical research experience, over 15 years in clinical management of thoracic, skin, and urologic cancers, and over 10 years in the field of endothelial cell biology, tumor angiogenesis, and cancer immunotherapy, and over 5 years in anticancer drug development. Arek is a Professor in the College of Medicine at the University of Illinois, Chicago and serves as the Head of the Clinical Trial Office of University of Illinois Cancer Center and a Phase 1 Unit for Cancer Therapeutics.